Tandem Diabetes Care TNDM FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Tandem Diabetes Care in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Tandem Diabetes Care’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tandem Diabetes Care's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tandem Diabetes Care's FX effect on cash?
- Tandem Diabetes Care (TNDM) reported FX effect on cash of -$1.08M in Q1 2026.
- How has Tandem Diabetes Care's FX effect on cash changed year-over-year?
- Tandem Diabetes Care's FX effect on cash increased by 42.8% year-over-year, from -$1.88M to -$1.08M.
- What is the long-term trend for Tandem Diabetes Care's FX effect on cash?
- Over 3 years (2021 to 2025), Tandem Diabetes Care's FX effect on cash has grown at a 119.2% compound annual growth rate (CAGR), from $153K to $1.61M.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.